Publications by authors named "Seyma CaliS"

Claim this Profile
A
A novel BH3 mimetic Bcl-2 inhibitor promotes autophagic cell death and reduces in vivo Glioblastoma tumor growth.
Seyma Calis, Berna Dogan, Serdar Durdagi, Asuman Celebi, Ozlem Yapicier

Cell Death Discov· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of SARS-CoV-2: A Combined in silico and in vitro Study.
Serdar Durdagi, Muge Didem Orhan, Busecan Aksoydan, Seyma Calis, Berna Dogan

Mol Inform· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The neutralization effect of montelukast on SARS-CoV-2 is shown by multiscale in silico simulations and combined in vitro studies.
Serdar Durdagi, Timucin Avsar, Muge Didem Orhan, Muge Serhatli, Bertan Koray Balcioglu, Seyma Calis

Mol Ther· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Near-physiological-temperature serial crystallography reveals conformations of SARS-CoV-2 main protease active site for improved drug repurposing.
Serdar Durdagi, Çağdaş Dağ, Berna Dogan, Merve Yigin, Timucin Avsar, Seyma Calis

Structure· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of MTHFR, MTRR and RAD54L Gene Variations with Meningioma and Correlation with Tumor's Histopathological Characteristics on Turkish Cohort.
Timucin Avsar, Rashid Mohiyuddin, Seyma Calis, Ozlem Yapicier, Turker Kilic

Turk Neurosurg· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide identification of Chiari malformation type I associated candidate genes and chromosomal variations.
Timuçin AvŞar, Şeyma ÇaliŞ, Baran Yilmaz, Gülden Demİrcİ OtluoĞlu, Can Holyavkİn

Turk J Biol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating Ligand and Target-Driven Based Virtual Screening Approaches With Human Cell Line Models and Time-Resolved Fluorescence Resonance Energy Transfer Assay to Identify Novel Hit Compounds Against BCL-2.
Gurbet Tutumlu, Berna Dogan, Timucin Avsar, Muge Didem Orhan, Seyma Calis

Front Chem· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis